However, regarding IL-6, tocilizumab is a medication that blocks the IL-6 receptor, inhibiting IL-6 signaling; this medication is part of the standard of care for treatment of other autoimmune diseases such as rheumatoid arthritis (RA). Here, IL6 is linked to autoimmune disease.